pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,683 catalysts · 6,366 phase readout · 2,311 8k filing · 389 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 20 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,366
  • 8k filing2,311
  • earnings389
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT03716349: Esthetics of Dental Composite and Adhesive System

Sponsor: Erica Teixeira. Phase: NA. Conditions: Cavities of Teeth

full page →ctgov ↗
›RECRUITINGphase readoutNCT06144749: A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)

Sponsor: Hillhurst Biopharmaceuticals, Inc.. Phase: PHASE1. Conditions: Anemia, Sickle Cell

full page →ctgov ↗
›COMPLETEDphase readoutNCT05693038: Brachial Plexus Injury After Prone Positioning

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Phase: . Conditions: Brachial Plexus Injury, Nerve Compression

full page →ctgov ↗
›COMPLETEDphase readoutNCT06782438: Evaluation of an Artificial Intelligence Algorithm Reducing Noise on Fast Whole-body Bone Tomoscintigraphy Acquisitions Recorded by a 360 Degree Cadmium-Zinc-Tellurid Camera

Sponsor: Central Hospital, Nancy, France. Phase: . Conditions: Bone Scan

full page →ctgov ↗
›RECRUITINGphase readoutNCT05209438: Cereset Research for Caregivers

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Caregivers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07221838: A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE4. Conditions: Generalized Myasthenia Gravis, gMG

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06062238: Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults

Sponsor: Gates Medical Research Institute. Phase: PHASE3. Conditions: Tuberculosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07747038: Caudal Block v/s Local Wound Infiltration for Pain Control in Pediatric Patients After Operation for Inguinal Hernia

Sponsor: Fatima Memorial Hospital. Phase: NA. Conditions: Postoperative Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07658638: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TESP-0401 in Healthy Participants

Sponsor: Tes Pharma S.r.l.. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07292038: Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors

Sponsor: NucMito Pharmaceuticals Co. Ltd.. Phase: PHASE1. Conditions: Cancers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07336238: Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Sponsor: University of Washington. Phase: PHASE2. Conditions: Anxiety, Depression, Hematopoietic and Lymphatic System Neoplasm, Metastatic Malignant Solid Neoplasm

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07223138: A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis

Sponsor: MoonLake Immunotherapeutics AG. Phase: PHASE3. Conditions: Arthritis, Psoriatic

full page →ctgov ↗
›COMPLETEDphase readoutNCT02926547: New Approaches for the Identification and Characterization of Functional Markers of the Risk of Extension of Breast Cancer Without Lymph Node Involvement

Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05358249: Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Nonsmall Cell Lung Cancer, Colorectal Cancer, Colorectal Carcinoma, Colorectal Neoplasms, Colorectal Tumors, Neoplasms, Colorectal

full page →ctgov ↗
›RECRUITINGphase readoutNCT07434349: Exercise Timing and Postprandial Glucose Responses

Sponsor: Technical University of Munich. Phase: NA. Conditions: Exercise Timing, Postprandial Glucose

full page →ctgov ↗
›RECRUITINGphase readoutNCT07531849: Nutrition Labelling Education Program in Socioeconomically Vulnerable Areas

Sponsor: University of Paris 13. Phase: NA. Conditions: Self-Efficacy, Food Choices, Understanding of Front-of-pack Labeling

full page →ctgov ↗
›COMPLETEDphase readoutNCT07335549: Istmin Levels in Laparoscopik Sleeve Gastrectomy

Sponsor: Saglik Bilimleri Universitesi. Phase: . Conditions: Obesity & Overweight, Sleeve Gastrectomy, Adipokines

full page →ctgov ↗
›RECRUITINGphase readoutNCT06203938: Autism Research Project With Non-Invasive Near-Infrared Light Stimulation

Sponsor: Francisco Gonzalez-Lima, PhD. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07371338: Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients

Sponsor: Innopeutics Corporation. Phase: PHASE1. Conditions: Parkinson Disease, Parkinson's Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07358338: Application of Device-based Training to Improve Postural Control in Older Adults With CCI

Sponsor: Litvina Lyubov Dmitrievna. Phase: NA. Conditions: Cerebrovascular Disorders, Gait Disorders, Neurologic, Accidental Fall, Aged, Postural Balance

full page →ctgov ↗
›RECRUITINGphase readoutNCT06692738: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06495658: Impact of Prebiotics in Ulcerative Colitis

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Crohn Disease, Ulcerative Colitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05085548: ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

Sponsor: ProDa BioTech, LLC. Phase: PHASE1. Conditions: Advanced Pancreatic Cancer, Solid Tumor Malignancies

full page →ctgov ↗
›COMPLETEDphase readoutNCT04630626: Post-Approval Study Protocol for the Simplify Cervical Artificial Disc

Sponsor: NuVasive. Phase: NA. Conditions: Cervical Degenerative Disc Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06002126: Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Cervix Cancer, HPV Infection, Cervical High Grade Squamous Intraepithelial Lesion, HIV Infections

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07662226: Taste Acceptance and Effectiveness of Hyaluronic Acid and Chlorhexidine Mouthwashes in Children With Gingivitis

Sponsor: Cairo University. Phase: PHASE1. Conditions: Plaque Induced Gingival Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07706348: Intraperitoneal Irrigation of Ondansteron in Combination With Lidocaine in Acute Postoperative Pain

Sponsor: Assiut University. Phase: PHASE1. Conditions: Acue Postoperative Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06866548: Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Sponsor: Shanghai Changzheng Hospital. Phase: EARLY_PHASE1. Conditions: mCRPC

full page →ctgov ↗
›RECRUITINGphase readoutNCT07732855: Treatment of Ocular Surface Inflammations

Sponsor: Semmelweis University. Phase: . Conditions: Ocular Surface Allergy, Conjunctivitis, Allergic, Blepharoconjunctivitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04237155: French Source-monitoring Task

Sponsor: Hôpital le Vinatier. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07595926: Height Measurement Procedures Influence the Risk of Ventilator-induced Lung Injury in ARDS

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Acute Respiratory Distress Syndrome, Ventilator-Induced Lung Injury, Tidal Volume, Predicted Body Weight, Height

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04327778: Automate Music Therapy for the Management of Behavioral Disorders in Nursing Homes

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Alzheimer Disease, Major Neurocognitive Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07380178: The Effect of Apple Fruit Extract (Malus Sylvestris Mill) as an Antioxidant and Anti-Inflammatory on Allergic Rhinitis

Sponsor: Universitas Sebelas Maret. Phase: NA. Conditions: Rhinitis, Allergic, Perennial

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07587385: A Study of HS-10506 in Chinese Patients With Insomnia Disorder

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Insomnia Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06260943: Targeted Navigation in Hepatocellular Carcinoma (HCC)

Sponsor: University of Miami. Phase: NA. Conditions: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatobiliary Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT04969835: A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

Sponsor: Avacta Life Sciences Ltd. Phase: PHASE1. Conditions: Salivary Gland Tumor, Urothelial Carcinoma, Ovarian Carcinoma, Breast Cancer, Soft Tissue Sarcoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07043335: Comparison of the Efficacy of Mesotherapy and Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis

Sponsor: Haydarpasa Numune Training and Research Hospital. Phase: NA. Conditions: Lateral Epicondylitis, Tennis Elbow

full page →ctgov ↗
›RECRUITINGphase readoutNCT02693535: TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Sponsor: American Society of Clinical Oncology. Phase: PHASE2. Conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07507825: Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Sponsor: First People's Hospital of Hangzhou. Phase: PHASE2. Conditions: Acute Myeloid Leukemia (AML)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07416825: Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Esophageal Cancer, Esophageal Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06647576: Exploring Neurosphere's Remote Monitoring and Virtual Clinic Features in Improve Quality of Life and Reduce Costs

Sponsor: Mahesh Pattabiraman. Phase: . Conditions: Chronic Neuropathic Pain, Chronic Pain Management, Spinal Cord Stimulation (SCS), Pain Modulation, Failed Back Surgery Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT03953976: INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy

Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07674576: Efficacy of Intravenous Dexamethasone in Prolonging the Duration of Spinal Anesthesia With Chloroprocaine in Knee Arthroscopy

Sponsor: CMC Ambroise Paré. Phase: PHASE3. Conditions: Knee Arthroscopy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07469176: Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With Down Syndrome

Sponsor: Northwestern University. Phase: NA. Conditions: Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT07234357: Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia

Sponsor: National Cancer Centre, Singapore. Phase: NA. Conditions: Mild Cognitive Impairment, Mild Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT05933057: Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

Sponsor: Italfarmaco. Phase: PHASE3. Conditions: Duchenne Muscular Dystrophy

full page →ctgov ↗
›COMPLETEDphase readoutNCT03172975: Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection

Sponsor: Baylor College of Medicine. Phase: PHASE2. Conditions: Hookworm Infections

full page →ctgov ↗
›COMPLETEDphase readoutNCT07114575: Gait Characteristics at Different Speeds in Individuals With Stroke

Sponsor: Ankara Yildirim Beyazıt University. Phase: . Conditions: Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT01223157: Saliva and Plasma Endocannabinoids Concentrations According to Feeding Status and Body Mass Index

Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT06534957: Online Mindfulness-based Stress Reduction for Patients Receiving Chemotherapy

Sponsor: Medicos e Investigadores en la Lucha contra el Cancer de Mama. Phase: NA. Conditions: Breast Cancer, Stress

full page →ctgov ↗
← prev
page 159 of 174
next →